Clinical Roundup UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma March 28, 2025Vol.51 No.12
Clinical Roundup Mutated cells can persist for years without becoming cancer and need an inflammatory “push” for malignancy to occur, COH study shows March 28, 2025Vol.51 No.12
Clinical Roundup AI tool helps predict who will benefit from focal therapy for prostate cancer, study shows March 21, 2025Vol.51 No.11
Clinical Roundup Shorter radiation treatment approach shows safety and efficacy for early-stage prostate cancer March 21, 2025Vol.51 No.11
Clinical Roundup Elahere shows survival benefit in long-term analysis for ovarian cancer patients in phase III study March 21, 2025Vol.51 No.11
Clinical Roundup Genmab’s Rina-S shows promise in treating advanced ovarian cancer March 21, 2025Vol.51 No.11
Clinical Roundup KRAS mutation is a significant predictor of metastasis and survival in pancreatic cancer, study shows March 21, 2025Vol.51 No.11
Clinical Roundup A post-treatment blood test could inform future cancer therapy decisions, study shows March 21, 2025Vol.51 No.11
Clinical Roundup Immunovia completes second clinical validation of next-gen pancreatic cancer test March 21, 2025Vol.51 No.11
Clinical Roundup Classifying childhood brain cancers by immune response may improve diagnostics and treatments March 21, 2025Vol.51 No.11
